Project Grant K01EB033870
Award Date
6/14/24
Completion Date
4/30/27
Dollars Obligated
$505K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This $598,952 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of a novel human stem cell-derived multi-cellular model to study midline crossing of axons in the spinal cord. The award will enable the generation and functional characterization of human neural organoids resembling the floor plate and dorsal spinal...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $385,500.00 to The Leland Stanford Junior University to develop a novel synthetic biology platform. This platform will consist of an inducible and multiplexed dual gene modulation system capable of simultaneously activating and repressing specific genes known to regulate...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $460,500 to develop novel bioprinting methodologies for producing human stem cell-based organoids for pharmacological screening. The key objectives are to create a customized bioink formulation that can foster the differentiation of stem cells into functional neurons,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to develop innovative magnetically responsive electrospun fiber scaffolds capable of on-demand, tailored delivery of therapeutics to mitigate inflammation and support neural regeneration following spinal cord injury (SCI). The $151,559 award to Rensselaer Polytechnic...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,976 to Ecate LLC aims to develop a novel intraspinal stimulator system to restore sensation and volitional motor control in spinal cord injury patients. The project will fabricate nanopatterned stimulating electrodes coupled with custom CMOS chips to deliver spatially selective electrical stimulation to the spinal cord. This closed-loop neural interface system is intended...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $559,496 to Northwestern University to refine induced pluripotent stem cell (iPSC)-based spinal cord model systems. The key objectives are to: Use biochemical purification and mass spectrometry to define the composition and temporal remodeling of the extracellular matrix (ECM) in mouse spinal cords across development. Leverage expertise in iPSC technologies and biomaterials to...
This $270,000 federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports research to elucidate cell state changes and molecular mechanisms associated with spinal cord regeneration versus failure in zebrafish following injury. The project aims to 1) define cell state changes over time related to regeneration and failure, and 2) manipulate...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research at Yale University focused on understanding the capacity and necessity of the raphespinal tract to support rehabilitation-induced functional recovery after spinal cord injury. The research will use anatomy, spatial transcriptomics, and intersectional in vivo chemogenetics...
The federal Project Grant award of $1,576,368 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will fund an evaluation of electrical stimulation during nerve transfer surgery for cervical spinal cord injury at Stanford University. The grant, awarded on August 1, 2024, with a completion date of July 31, 2027, will support innovative research to develop advanced medical treatments for this condition. As a leading research institution,...
This National Science Foundation (NSF) Engineering (CFDA 47.041) Program grant award, totaling $531,543, aims to develop novel soft, injectable, and stretchable hydrogel-based electrodes for spinal cord injury treatments. The key goals are to: (1) create biocompatible hydrogel materials with high electrical performance for neural interfaces; (2) develop minimally invasive, surgery-free hydrogel intraspinal electrodes for long-term stability; and (3) demonstrate therapeutic potential of...